Literature DB >> 24461999

Nanog is dispensable for the generation of induced pluripotent stem cells.

Benjamin A Schwarz1, Ori Bar-Nur2, José C R Silva3, Konrad Hochedlinger4.   

Abstract

Cellular reprogramming from somatic cells to induced pluripotent stem cells (iPSCs) can be achieved through forced expression of the transcription factors Oct4, Klf4, Sox2, and c-Myc (OKSM) [1-4]. These factors, in combination with environmental cues, induce a stable intrinsic pluripotency network that confers indefinite self-renewal capacity on iPSCs. In addition to Oct4 and Sox2, the homeodomain-containing transcription factor Nanog is an integral part of the pluripotency network [5-11]. Although Nanog expression is not required for the maintenance of pluripotent stem cells, it has been reported to be essential for the establishment of both embryonic stem cells (ESCs) from blastocysts and iPSCs from somatic cells [10, 12]. Here we revisit the role of Nanog in direct reprogramming. Surprisingly, we find that Nanog is dispensable for iPSC formation under optimized culture conditions. We further document that Nanog-deficient iPSCs are transcriptionally highly similar to wild-type iPSCs and support the generation of teratomas and chimeric mice. Lastly, we provide evidence that the presence of ascorbic acid in the culture media is critical for overcoming the previously observed reprogramming block of Nanog knockout cells.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24461999      PMCID: PMC4007021          DOI: 10.1016/j.cub.2013.12.050

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  25 in total

1.  Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells.

Authors:  Ian Chambers; Douglas Colby; Morag Robertson; Jennifer Nichols; Sonia Lee; Susan Tweedie; Austin Smith
Journal:  Cell       Date:  2003-05-30       Impact factor: 41.582

2.  "Stemness": transcriptional profiling of embryonic and adult stem cells.

Authors:  Miguel Ramalho-Santos; Soonsang Yoon; Yumi Matsuzaki; Richard C Mulligan; Douglas A Melton
Journal:  Science       Date:  2002-09-12       Impact factor: 47.728

3.  Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells.

Authors:  Matthias Stadtfeld; Effie Apostolou; Hidenori Akutsu; Atsushi Fukuda; Patricia Follett; Sridaran Natesan; Tomohiro Kono; Toshi Shioda; Konrad Hochedlinger
Journal:  Nature       Date:  2010-04-25       Impact factor: 49.962

4.  The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells.

Authors:  Kaoru Mitsui; Yoshimi Tokuzawa; Hiroaki Itoh; Kohichi Segawa; Mirei Murakami; Kazutoshi Takahashi; Masayoshi Maruyama; Mitsuyo Maeda; Shinya Yamanaka
Journal:  Cell       Date:  2003-05-30       Impact factor: 41.582

5.  Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase.

Authors:  Yosef Buganim; Dina A Faddah; Albert W Cheng; Elena Itskovich; Styliani Markoulaki; Kibibi Ganz; Sandy L Klemm; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

6.  A molecular roadmap of reprogramming somatic cells into iPS cells.

Authors:  Jose M Polo; Endre Anderssen; Ryan M Walsh; Benjamin A Schwarz; Christian M Nefzger; Sue Mei Lim; Marti Borkent; Effie Apostolou; Sara Alaei; Jennifer Cloutier; Ori Bar-Nur; Sihem Cheloufi; Matthias Stadtfeld; Maria Eugenia Figueroa; Daisy Robinton; Sridaran Natesan; Ari Melnick; Jinfang Zhu; Sridhar Ramaswamy; Konrad Hochedlinger
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

7.  Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells.

Authors:  Matthias Stadtfeld; Effie Apostolou; Francesco Ferrari; Jiho Choi; Ryan M Walsh; Taiping Chen; Steen S K Ooi; Sang Yong Kim; Timothy H Bestor; Toshi Shioda; Peter J Park; Konrad Hochedlinger
Journal:  Nat Genet       Date:  2012-03-04       Impact factor: 38.330

8.  Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain.

Authors:  Thorold W Theunissen; Yael Costa; Aliaksandra Radzisheuskaya; Anouk L van Oosten; Fabrice Lavial; Bertrand Pain; L Filipe C Castro; José C R Silva
Journal:  Development       Date:  2011-11       Impact factor: 6.868

9.  Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells.

Authors:  Nicola Festuccia; Rodrigo Osorno; Florian Halbritter; Violetta Karwacki-Neisius; Pablo Navarro; Douglas Colby; Frederick Wong; Adam Yates; Simon R Tomlinson; Ian Chambers
Journal:  Cell Stem Cell       Date:  2012-10-05       Impact factor: 24.633

10.  Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells.

Authors:  Kathryn Blaschke; Kevin T Ebata; Mohammad M Karimi; Jorge A Zepeda-Martínez; Preeti Goyal; Sahasransu Mahapatra; Angela Tam; Diana J Laird; Martin Hirst; Anjana Rao; Matthew C Lorincz; Miguel Ramalho-Santos
Journal:  Nature       Date:  2013-06-30       Impact factor: 49.962

View more
  35 in total

1.  The primary role of zebrafish nanog is in extra-embryonic tissue.

Authors:  James A Gagnon; Kamal Obbad; Alexander F Schier
Journal:  Development       Date:  2018-01-09       Impact factor: 6.868

2.  Stem cell mechanics: auxetic nuclei.

Authors:  Ning Wang
Journal:  Nat Mater       Date:  2014-06       Impact factor: 43.841

Review 3.  Molecular control of induced pluripotency.

Authors:  Thorold W Theunissen; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2014-06-05       Impact factor: 24.633

4.  Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells.

Authors:  Yohei Hayashi; Laura Caboni; Debanu Das; Fumiaki Yumoto; Thomas Clayton; Marc C Deller; Phuong Nguyen; Carol L Farr; Hsiu-Ju Chiu; Mitchell D Miller; Marc-André Elsliger; Ashley M Deacon; Adam Godzik; Scott A Lesley; Kiichiro Tomoda; Bruce R Conklin; Ian A Wilson; Shinya Yamanaka; Robert J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

Review 5.  Master regulators in development: Views from the Drosophila retinal determination and mammalian pluripotency gene networks.

Authors:  Trevor L Davis; Ilaria Rebay
Journal:  Dev Biol       Date:  2016-12-13       Impact factor: 3.582

Review 6.  Dynamic stem cell states: naive to primed pluripotency in rodents and humans.

Authors:  Leehee Weinberger; Muneef Ayyash; Noa Novershtern; Jacob H Hanna
Journal:  Nat Rev Mol Cell Biol       Date:  2016-02-10       Impact factor: 94.444

7.  X chromosome reactivation dynamics reveal stages of reprogramming to pluripotency.

Authors:  Vincent Pasque; Jason Tchieu; Rahul Karnik; Molly Uyeda; Anupama Sadhu Dimashkie; Dana Case; Bernadett Papp; Giancarlo Bonora; Sanjeet Patel; Ritchie Ho; Ryan Schmidt; Robin McKee; Takashi Sado; Takashi Tada; Alexander Meissner; Kathrin Plath
Journal:  Cell       Date:  2014-12-18       Impact factor: 41.582

Review 8.  Molecular basis of embryonic stem cell self-renewal: from signaling pathways to pluripotency network.

Authors:  Guanyi Huang; Shoudong Ye; Xingliang Zhou; Dahai Liu; Qi-Long Ying
Journal:  Cell Mol Life Sci       Date:  2015-01-17       Impact factor: 9.261

Review 9.  Mechanisms of pluripotency maintenance in mouse embryonic stem cells.

Authors:  Chen-Yun Chen; Yuan-Yuan Cheng; Christopher Y T Yen; Patrick C H Hsieh
Journal:  Cell Mol Life Sci       Date:  2016-12-20       Impact factor: 9.261

10.  A genome-wide RNAi screen identifies opposing functions of Snai1 and Snai2 on the Nanog dependency in reprogramming.

Authors:  Julian A Gingold; Miguel Fidalgo; Diana Guallar; Zerlina Lau; Zhen Sun; Hongwei Zhou; Francesco Faiola; Xin Huang; Dung-Fang Lee; Avinash Waghray; Christoph Schaniel; Dan P Felsenfeld; Ihor R Lemischka; Jianlong Wang
Journal:  Mol Cell       Date:  2014-09-15       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.